A
Atsuo Taniguchi
Researcher at Toshiba
Publications - 184
Citations - 7113
Atsuo Taniguchi is an academic researcher from Toshiba. The author has contributed to research in topics: Rheumatoid arthritis & Arthritis. The author has an hindex of 36, co-authored 184 publications receiving 6180 citations.
Papers
More filters
Journal ArticleDOI
Functional disability can deteriorate despite suppression of disease activity in patients with rheumatoid arthritis: a large observational cohort study
Yohei Seto,Eisuke Inoue,Kumi Shidara,Daisuke Hoshi,Naoki Sugimoto,Eri Sato,Eiichi Tanaka,Ayako Nakajima,Atsuo Taniguchi,Shigeki Momohara,Hisashi Yamanaka +10 more
TL;DR: There is some disparity between improvement of disease activity and progression of disability, suggesting that quality of remission must be considered.
Journal ArticleDOI
Disability is the major negative predictor for achievement of Boolean-based remission in patients with rheumatoid arthritis treated with tocilizumab
Daisuke Hoshi,Ayako Nakajima,Kumi Shidara,Yohei Seto,Eiichi Tanaka,Atsuo Taniguchi,Shigeki Momohara,Hisashi Yamanaka +7 more
TL;DR: This study suggests that baseline disability predicts a lack of achievement of Boolean-based remission, and better responses to TCZ may be obtained when TCZ is initiated in RA patients before disability develops.
Journal ArticleDOI
Incidence of comprehensive hospitalization due to infection, cardiovascular disease, fractures, and malignancies in patients with rheumatoid arthritis
Naoki Sugimoto,Ayako Nakajima,Eisuke Inoue,Kumi Shidara,Hiroyuki Yamashita,Akio Mimori,Hitoshi Tokuda,Yohei Seto,Eiichi Tanaka,Shigeki Momohara,Atsuo Taniguchi,Hisashi Yamanaka +11 more
TL;DR: The present study determined the overall burden of hospitalized comorbidities in patients with RA and believes this data may provide a basis for future improvements in the treatment of RA.
Journal ArticleDOI
Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012.
Eri Sato,Eiichi Tanaka,Moeko Ochiai,Y. Shimizu,Akiko Kobayashi,Kumi Shidara,Daisuke Hoshi,Naoki Sugimoto,Eisuke Inoue,Yohei Seto,Ayako Nakajima,Atsuo Taniguchi,Shigeki Momohara,Hisashi Yamanaka +13 more
TL;DR: Baseline disease activity of RA patients who received biologic DMARDs between 2003 and 2012 has changed from high to moderate in daily practice in Japan.
Journal ArticleDOI
Efficacy of adjunct tacrolimus treatment in patients with rheumatoid arthritis with inadequate responses to methotrexate
Mariko Kitahama,Ayako Nakajima,Eisuke Inoue,Atsuo Taniguchi,Shigeki Momohara,Hisashi Yamanaka +5 more
TL;DR: This study demonstrated the efficacy of add-on therapy with TAC to MTX in patients with RA in daily practice.